PURPOSE: Chronic renal failure patients undergoing peritoneal dialysis (PD) are characterized by increased oxidative stress (OS), which is associated with enhanced cardiovascular risk. Moreover, oxidative stress also contributes to peritoneal membrane changes and ultrafiltration failure. The aim of this study was to evaluate OS in PD patients and the effect of treatment with ascorbic acid and α-tocopherol. METHODS: Plasma, erythrocyte, urine, and peritoneal effluent samples from 20 patients on PD were evaluated for glutathione peroxidase and superoxide dismutase activity, total antioxidant capacity (TAC) and malondialdehyde (MDA) levels, as well as protein carbonyl formation, before and after administration of vitamin C, alone or in combination with vitamin E, in comparison with 10 apparently healthy control individuals. RESULTS: All studied markers showed enhanced OS in the PD group, compared to controls. The supplementation of vitamin C and E resulted in improvements of all the OS markers, as indicated by increased erythrocyte antioxidant enzymes activity and TAC levels, as well as decreased MDA concentration and carbonyl compound formation. CONCLUSIONS: The oral supplementation of antioxidant vitamins C and E, in combination, can lead to decreased OS, thus providing a useful and cost-effective therapeutic option in PD patients.
PURPOSE:Chronic renal failurepatients undergoing peritoneal dialysis (PD) are characterized by increased oxidative stress (OS), which is associated with enhanced cardiovascular risk. Moreover, oxidative stress also contributes to peritoneal membrane changes and ultrafiltration failure. The aim of this study was to evaluate OS in PDpatients and the effect of treatment with ascorbic acid and α-tocopherol. METHODS: Plasma, erythrocyte, urine, and peritoneal effluent samples from 20 patients on PD were evaluated for glutathione peroxidase and superoxide dismutase activity, total antioxidant capacity (TAC) and malondialdehyde (MDA) levels, as well as protein carbonyl formation, before and after administration of vitamin C, alone or in combination with vitamin E, in comparison with 10 apparently healthy control individuals. RESULTS: All studied markers showed enhanced OS in the PD group, compared to controls. The supplementation of vitamin C and E resulted in improvements of all the OS markers, as indicated by increased erythrocyte antioxidant enzymes activity and TAC levels, as well as decreased MDA concentration and carbonyl compound formation. CONCLUSIONS: The oral supplementation of antioxidant vitamins C and E, in combination, can lead to decreased OS, thus providing a useful and cost-effective therapeutic option in PDpatients.
Authors: T Nguyen-Khoa; Z A Massy; J P De Bandt ; M Kebede; L Salama; G Lambrey; V Witko-Sarsat; T B Drüeke; B Lacour; M Thévenin Journal: Nephrol Dial Transplant Date: 2001-02 Impact factor: 5.992
Authors: K Honda; K Nitta; S Horita; W Yumura; H Nihei; R Nagai; K Ikeda; S Horiuchi Journal: Nephrol Dial Transplant Date: 1999-06 Impact factor: 5.992
Authors: Linda F Fried; Michael G Shlipak; Casey Crump; Anthony J Bleyer; John S Gottdiener; Richard A Kronmal; Lewis H Kuller; Anne B Newman Journal: J Am Coll Cardiol Date: 2003-04-16 Impact factor: 24.094
Authors: Johannes F E Mann; Eva M Lonn; Qilong Yi; Hertzel C Gerstein; Byron J Hoogwerf; Janice Pogue; Jackie Bosch; Gilles R Dagenais; Salim Yusuf Journal: Kidney Int Date: 2004-04 Impact factor: 10.612
Authors: Jean A Hall; Jennifer MacLeay; Maha Yerramilli; Edward Obare; Murthy Yerramilli; Heidi Schiefelbein; Inke Paetau-Robinson; Dennis E Jewell Journal: PLoS One Date: 2016-04-18 Impact factor: 3.240
Authors: Jean A Hall; Jennifer MacLeay; Maha Yerramilli; Edward Obare; Murthy Yerramilli; Heidi Schiefelbein; Inke Paetau-Robinson; Dennis E Jewell Journal: PLoS One Date: 2016-04-14 Impact factor: 3.240
Authors: Diana Nabrdalik-Leśniak; Katarzyna Nabrdalik; Katarzyna Sedlaczek; Patryk Główczyński; Hanna Kwiendacz; Tomasz Sawczyn; Weronika Hajzler; Karolina Drożdż; Mirela Hendel; Krzysztof Irlik; Paweł Stelmach; Piotr Adamczyk; Andrzej Paradysz; Sławomir Kasperczyk; Tomasz Stompór; Janusz Gumprecht Journal: Oxid Med Cell Longev Date: 2021-07-14 Impact factor: 6.543